23 January - Lynne Cox (University of Oxford)
20 March - Richard Festenstein (Imperial Collage London)
17 April - Panagia Filippakopoulos (SGC,University of Oxford)
22 May - Rob Klose (University of Oxford)
20 November - Delphine Larrieu (University of Cambridge)
2017 BCGB Seminar series
21 February - Dr Veronique Azuara (Faculty of Medicine, Imperial College, London)
21 March - Dr Cristina Lo Celso (Francis Crick Institute, London)
25 April - Dr Petra Hajkova (MRC Clinical Science Centre, Imperial College, London)
9 May - Dr Chiara Francavilla (Faculty of Life Science, University of Manchester)
13 June - Professor Adam Mead (Radcliffe Department of Medicine, University of Oxford)
26 September - Narvaez (Astra Zeneca)
21 November - Andrew Jackson (University of Edinburgh)
5 December - Duncan Odem (Cancer Research UK Cambridge Institute)
19 January - Florian Grebian (Ludwig Boltxmann Institute for Cancer Research), "Identification of critical effectors of C/EBPalpha mutant AML".
16 February - Professor Elias Campo (Research Director, Hospital Clinic, Barcelona), “Clinical impact of recurrent coding and non-coding mutations in CLL”.
19 February - Professor Daniel G. Tenen (Director of the Blood Program of the Harvard Stem Cell Institute, Director of the Cancer Science Institute of Singapore), “Epigenetic regulation by RNA in a normal and malignant context”.
15 March - Professor Dean Jackson (University of Manchester), “Activation of signalling through the NF-kappaB and p53 stress response networks: mapping signalling oscillations to cell fate".
19 April - Dr Adele Murrell (University of Bath), “Models for studying epigenetic gene regulation in breast cancer”.
24 May - Professor Claus Nerlov (University of Oxford), “Dissecting hematopoietic stem- and progenitor cell populations using molecular and functional single cell approaches”.
20 September - Professor Tom Owen-Hughes (University of Dundee), “Structural and genomic insights into chromatin organisation”.
21 September - Dr David Blakey (Mina Therapeutics), “Pioneering small activating RNA oligonucleotides for transcriptional activation: Preclinical studies on MTL-CEBPA
29 November - Dr Sarah McClelland (Barts Cancer Institute, London)
13 December - Dr Nathalia Gromak (Sir William Dunn School of Pathology, Oxford)
25 February - Francis Stewart (University of Dresden), "Regulation of the Genome by MLL Family Histone Methyl Transferases".
17 March - Peter Fraser (Babraham Institute),"3D Structure and Function of the Genome: from Cell Populations to Single Cell Analyses".
21 April - Marco Saponaro (Francis Crick Institute), "Transcription Regulation in the Context of Genome Stability Maintenance".
19 May - Bertie Gottgens (University of Cambridge), "Single Cell Biology Links Cellular Function with Molecular Profile to Reveal Gene Regulatory Networks".
16 June - Paola Scaffidi, "Epigenetics and functional intra-tumour heterogeneity".
25 June - Professor Ann Harris (Northwestern University, Chicago), "Coordinating epithelial function: from single locus to transcriptional network".
8 September - Dirk Schübeler (Friedrich Miescher Institute for Biomedical Research, Basel), "Reading and writing DNA methylation".
8 September - Asifa Akhtar (Max Planck Institute of Immunology and Epigenetics, Freiburg). "Epigenetic regulation by MOF containing complexes".
23 October - John Bushweller (University of Virginia), "Drugging the undruggable – Targeting transcription factors for cancer therapy".
24 November - Dr Marco Saponaro (Institute of Cancer and Genomic Sciences), “ Transcription regulation in the context of genome stability maintenance”.
1 December - Dr Tatjana Sauka-Spengler, Associate Professor of Genome Biology, MRC Senior Research Fellow, University of Oxford “Pioneering the chromatin for neural crest specification”.